EU funds firm developing virus vaccine amid US interest

A newspaper said President Donald Trump had offered CureVac a large amount of money

Coronavirus stifles life in US; Trump issues tougher guidelines

BERLIN (AP) — The European Union is making a multimillion-dollar investment in a German company that is working on a coronavirus vaccine amid reports that the U.S. government expressed interest in acquiring the firm.

The funding, 80 million euros or about $89.4 million dollars, is part of a coordinated response by the EU to the coronavirus.

Citing unnamed government sources, a German newspaper had reported that President Donald Trump had offered CureVac a large amount of money to secure its work for the U.S.

The White House said it was not aware of the “underlying information” in the newspaper report.

Copyright 2020 Associated Press. All rights reserved.